![Hiroki Takai](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hiroki Takai
Private Equity Investor at Global Brain Corp.
Profile
Hiroki joined GB in 2022 and is responsible for Life Science investments in Europe and Israel.
Hiroki started his career as a researcher, earning his PhD on the regulation of gene expression in the worst type of brain cancers at the University of Tokyo.
After graduation, He moved to Boston and conducted research at Harvard Medical School before joining Eli Lilly and Company.
At Eli Lilly, He led the interpretation of clinical trial results with a multinational and interdisciplinary team and devised strategies for disseminating scientific information through scientific articles and conference presentations.
During his MBA at London Business School, He worked for Lilly New Ventures, Eli Lilly's internal organization, investigating Japan's Life Science investment opportunities.
Hiroki enjoys weight training, photography (urban landscapes, architecture, and nature), driving boats, ocean fishing, and spending time with his family.
Hiroki Takai active positions
Companies | Position | Start |
---|---|---|
Global Brain Corp.
![]() Global Brain Corp. Investment ManagersFinance Global Brain Corp. (Global Brain) is an independent venture capital firm founded in 1998 by Yasuhiko Yurimoto. Global Brain Corp. is headquartered in Tokyo, Japan. | Private Equity Investor | 31/12/2021 |
Training of Hiroki Takai
University of Tokyo | Doctorate Degree |
London Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Global Brain Corp.
![]() Global Brain Corp. Investment ManagersFinance Global Brain Corp. (Global Brain) is an independent venture capital firm founded in 1998 by Yasuhiko Yurimoto. Global Brain Corp. is headquartered in Tokyo, Japan. | Finance |
- Stock Market
- Insiders
- Hiroki Takai